Integrated Proteins Limited has approved a 1:10 sub-division of its equity shares, reducing the face value from ₹10 to Re 1 to enhance liquidity and affordability for retail investors. The Board of Directors approved the split at its meeting held on July 9, 2026, subject to shareholder and regulatory approvals. The record date for the sub-division will be intimated subsequently. The authorized share capital will be adjusted to ₹25,00,00,000 divided into 25,00,00,000 equity shares of Re 1 each.

Share Capital Structure

The following table outlines the share capital structure before and after the sub-division:

Promoter Reclassification

The board also approved the reclassification of certain promoter and promoter group shareholders to the 'Public' category, including Vinod Prabhulal Mehta, Amrish Vinod Mehta, and Jyoti Vinodchandra Mehta, subject to a No Objection Certificate from BSE Limited. Additionally, the board accepted the resignations of Mr. Priyansh Tejas Parekh (Independent Director), Ms. Neepa Praful Kothari (Director), and Mr. Vinod Prabhulal Mehta (Executive Director), effective July 9, 2026, citing professional commitments.

Board Reconstitution

To fill the vacancies, the board appointed Mr. Nitish Pratapray Mehta as an Additional Non-Executive Director categorized as an Executive Director, and Mr. Hiren Dhirajlal Shah as an Additional Executive Director. Mr. Sandeep Mahadik was appointed as an Additional Non-Executive Independent Director for a term of five years from July 9, 2026, to June 8, 2031, subject to shareholder approval. The board also reconstituted the Audit Committee, Nomination and Remuneration Committee, and Stakeholders Relationship Committee with effect from July 9, 2026. The intimation was filed pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and confirmed by Shivangi Paliwal, Company Secretary and Compliance Officer.

Integrated Proteins Limited accepted the resignation of Karanj Dharmeshbhai Doshi as Managing Director effective from the close of business hours on June 29, 2026. The resignation was approved by the Board of Directors during a meeting held on Monday. Doshi cited personal reasons and priorities for stepping down, confirming there were no other material reasons for his departure.

Following the resignation, Doshi ceases to be a Key Managerial Person under Section 203 of the Companies Act, 2013, and Regulation 30(5) of the SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015. The Board meeting, which commenced at 17:45 HRS (IST) and concluded at 18:15 HRS (IST), also addressed the necessary procedural formalities associated with the change.

Resignation Details

The company disclosed the specifics of the change in leadership in a filing to BSE Limited. The resignation letter was submitted by Doshi on June 29, 2026, and accepted by the Board the same day.

The disclosure was made pursuant to Regulation 30 of the SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, read with SEBI Circular No. SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024. CS Shivangi Paliwal, Company Secretary and Compliance Officer, signed the regulatory filing on behalf of Integrated Proteins Limited.